Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases

被引:9
|
作者
Aymonier, M. [1 ]
Abed, S. [1 ]
Boye, T. [1 ]
Barazzutti, H. [2 ]
Fournier, B. [1 ]
Morand, J. -J. [1 ]
机构
[1] Hop Mil Ste Anne, Serv Dermatol, F-83800 Toulon, France
[2] Hop Mil Ste Anne, Serv Pneumol, F-83800 Toulon, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2017年 / 144卷 / 04期
关键词
Dermatomyositis; Anti-MDA5; auto-antibodies; Pneumocystis pneumonia; INTERSTITIAL LUNG-DISEASE; GENE; 5;
D O I
10.1016/j.annder.2016.09.677
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. - Dermatomyositis associated with anti-MDA-5 autoantibodies is a recently described clinical entity. Herein we report two lethal cases involving pneumocystis pneumonia. Patients and methods. - Case n degrees 1. A 56-year-old male patient developed cutaneous symptoms consistent with dermatomyositis without muscular involvement. Antinuclear antibodies were present and anti-MDA5 auto-antibodies were identified. The scan showed interstitial lung disease without infection. Significant improvement was obtained with corticosteroids. One month later, the patient presented acute respiratory illness (hypoxemia: PaO2 60 mmHg, exacerbation of lung disease evidenced by a scan, and diagnosis of pneumocystis pneumonia on bronchoalveolar lavage). He died despite appropriate antibiotic therapy and immunosuppressant therapy. Case n degrees 2. The second case concerned a 52-year-old Vietnamese man who developed more atypical cutaneous symptoms of dermatomyositis without muscular involvement. ANAb responses were positive (1/400) and MDA5 was present. The patient was treated with corticosteroids (40 mg/d), hydroxychloroquine, and intravenous immunoglobulin. After significant improvement, the patient developed an acute respiratory illness due to superinfection with pneumocystis and he died despite specific treatment and cyclophosphamide bolus. Conclusion. - In dermatomyositis, anti-MDA5 antibody screening is essential for the prognosis since the disease carries a risk of complication with severe lung disease. Bronchial fibroscopy with bronchoalveolar lavage should be considered at the time of diagnosis. Our two cases suggest the need for early screening for pneumocystis pneumonia in the event of respiratory distress and possibly for prophylactic treatment at the start of immunosuppressant therapy. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 50 条
  • [21] DIAGNOSTIC CHALLENGES IN ANTI-MDA5 ASSOCIATED CLINICALLY AMYOPATHIC DERMATOMYOSITIS
    McGoldrick, J.
    Schwab, P.
    Stenzel, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 146 - 146
  • [22] Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?
    Bader-Meunier, Brigitte
    Breton, Sylvain
    Duffy, Darragh
    Gitiaux, Cyril
    Quartier, Pierre
    Lemelle, Irene
    Meyer, Alain
    Welfringer-Morin, Anne
    Fremond, Marie-Louise
    Charuel, Jean-Luc
    Rodero, Mathieu P.
    Melki, Isabelle
    RHEUMATOLOGY, 2023, 62 (08) : E242 - E245
  • [23] GENETIC POLYMORPHISMS OF HLA-DRB1 ARE ASSOCIATED WITH DERMATOMYOSITIS AND ANTI-MDA5 ANTIBODIES IN CHINESE
    Wang, Y.
    Chen, Z.
    Sun, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 666 - 666
  • [24] Anti-MDA5 dermatomyositis mimicking psoriatic arthritis
    Cabezas-Rodriguez, Ivan
    Morante-Bolado, Isla
    Brandy-Garcia, Anahy
    Queiro-Silva, Ruben
    Mozo, Lourdes
    Javier Ballina-Garcia, Francisco
    REUMATOLOGIA CLINICA, 2018, 14 (04): : 224 - 226
  • [25] Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis
    Combalia, Andrea
    Giavedoni, Priscila
    Tamez, Lorena
    Grau-Junyent, Josep M.
    Mascaro, Jose M., Jr.
    JAMA DERMATOLOGY, 2018, 154 (03) : 371 - 373
  • [26] Relapsing Hematoma Secondary to Anti-MDA5 Dermatomyositis
    Zhu, Fenglin
    Li, Chengyin
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (03) : E17 - E17
  • [27] ANTI-MDA5 POSITIVE DERMATOMYOSITIS: AN EMERGING ENTITY
    Ortiz-Santamaria, V.
    Ponce, A.
    Busquets, N.
    Del Castillo, N.
    Suris, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1289 - 1289
  • [28] Hospitalization and Continuity of Care in Anti-MDA5 Dermatomyositis
    Richardson, William Mark
    Shah, Jill T.
    Mazori, Daniel R.
    Caplan, Avrom S.
    Lo Sicco, Kristen I.
    Femia, Alisa N.
    JAMA DERMATOLOGY, 2024, 160 (06) : 674 - 676
  • [29] A CASE OF COVID VACCINE-ASSOCIATED ANTI-MDA5 ANTIBODY DERMATOMYOSITIS
    Woodard, Vanessa
    Mann, Blake A.
    CHEST, 2023, 164 (04) : 3327A - 3328A
  • [30] Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis
    Ceribelli, A.
    Fredi, M.
    Taraborelli, M.
    Cavazzana, I.
    Tincani, A.
    Selmi, C.
    Chan, J. Y. F.
    Chan, E. K. L.
    Satoh, M.
    Franceschini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : 891 - 897